The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease
NAD-HD · Oslo University Hospital
Phase 2 study testing a dietary supplement to see whether it can slow the progression of Huntington's disease.
RecruitingPhase 2Dietary SupplementClinicalTrials.govTreatment trial
Recruiting in: Oslo, Norway
Preparing a short plain-English summary.
